نتایج جستجو برای: methylphenidate mph

تعداد نتایج: 6344  

Journal: :Mutation research 2009
Immaculada Ponsa Josep Antoni Ramos-Quiroga Marta Ribasés Rosa Bosch Anna Bielsa Maria Teresa Ordeig Marta Morell Rosa Miró Rafael de Cid Xavier Estivill Miquel Casas Mònica Bayés Bru Cormand Amaia Hervás

Attention-deficit/hyperactivity disorder (ADHD) is the most common psychiatric condition with onset in childhood, and in more than 50% of cases it persists into adulthood as a chronic disorder. Over five million methylphenidate (MPH) prescriptions were issued in the USA in 2003, mostly for children. A previous report [R.A. El-Zein, S.Z. Abdel-Rahman, M.J. Hay, M.S. Lopez, M.L. Bondy, D.L. Morri...

2015
Elisabeth Schapperer Heike Daumann Stéphane Lamouche Ursula Thyroff-Friesinger François Viel Werner Weitschies

The aim was to assess the bioequivalence of Sandoz methylphenidate osmotic-controlled release (OCR) tablets (Sandoz [Methylphenidate[ MPH OCR) with Concerta®, a methylphenidate formulation indicated for the treatment of attention deficit/hyperactivity disorder (ADHD). Four open-label, randomized, single-dose, two-way crossover bioequivalence studies were conducted in healthy subjects: three fas...

Kianifard D Mousavi Z,

Background: Methylphenidate (MPH), Ritalin, is one of the most common medications. The administration of Ritalin leads to increase of the activity of central nervous system. Ritalin may be used for maintaining alertness and improving of attention which may lead to increase of the risk of substance abuse in some cases. There is a little data about the effects of long term treatment with Methylph...

Background and Objective: Methylphenidate (MPH), as a central nervous system stimulant, is often used to manage hyperactive disorders. The literature is scarce regarding the behavioral consequences of chronic MPH treatment and the role of involved receptors. Thus, in the current study involved receptors in MPH induced-anxiety, depression and motor activity disorders were evaluated. Materials a...

2015
Kristen K. Leedy

The Synergistic Effects of Methylphenidate on the Behavioral Effects of Nicotine by Kristen K. Leedy One of the most common childhood disorders, attention-deficit hyperactivity disorder (ADHD) places individuals at a higher risk for nicotine (NIC) dependence. Approximately 37.2% of individuals with ADHD currently smoke compared to the 18.3% of individuals with no record of mental illness. Methy...

Journal: :Human psychopharmacology 2016
Kyoung Doo Kang Sin Weon Yun Unsun Chung Tae Ho Kim Jeong Ha Park In Hui Park Doug Hyun Han

OBJECTIVE The side effects of methylphenidate (MPH) on growth remain a controversial concern. This study aimed to investigate the effect of MPH on clinical symptoms, growth, and physical fitness in Korean children. METHODS Fifty male children with attention deficit hyperactivity disorder (ADHD) treated with methylphenidate (MPH-ADHD), 69 MPH-naïve male children with ADHD (Naïve-ADHD), and 60 ...

Journal: :Annals of General Psychiatry 2006
Jason E Kemner Maureen J Lage

BACKGROUND While stimulant therapy has been shown to be effective in the treatment of attention-deficit/hyperactivity disorder (ADHD), there is less information concerning differences between alternative stimulant medications. The purpose of this study is to examine how different formulations of methylphenidate (MPH) affect treatment patterns and hospitalizations. METHODS From a large claims ...

2013
Suzanne M. Czerniak Elif M. Sikoglu

Objective: Attention-deficit/hyperactivity disorder (ADHD) is a psychiatric disorder affecting 5% of children. Methylphenidate (MPH) is a common medication for ADHD. Studies examining MPH’s effect on pediatric ADHD patients’ brain function using functional magnetic resonance imaging (fMRI) have not been compiled. The goals of this systematic review were to determine (1) which areas of the brain...

2013
David Coghill Tobias Banaschewski Alessandro Zuddas Antonio Pelaz Antonella Gagliano Manfred Doepfner

BACKGROUND The stimulant methylphenidate (MPH) has been a mainstay of treatment for attention-deficit/hyperactivity disorder (ADHD) for many years. Owing to the short half-life and the issues associated with multiple daily dosing of immediate-release MPH formulations, a new generation of long-acting MPH formulations has emerged. Direct head-to-head studies of these long-acting MPH formulations ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید